Fixed Dose Combination Drugs: Why Govt Panel recommends ban on 343 medicine combos Ruby Khatun Khatun28 July 2018 1:17 PM ISTUnnecessary Overuse, Dosage Mismatch, Lack of Backup Studies were some of the reasons cited by the reportNew Delhi: An expert panel formed by an apex...
Sanofi Pasteur launches first Four-Strain Influenza Vaccine in India Ruby Khatun Khatun28 July 2018 11:00 AM ISTKolkata: Sanofi Pasteur, the vaccine division of Sanofi, announced the launch of its 4-strain influenza vaccine FluQuadri in India.FluQuadri will be...
USFDA inspects Dahej facility, no observations issued: Ajanta Pharma Ruby Khatun Khatun28 July 2018 10:45 AM ISTNew Delhi: Drug firm Ajanta Pharma said the US health regulator has not made any observations after completion of inspection of its Dahej facility in...
Dr Reddy's Labs Q1 net profit increases nearly eight-fold to Rs 456 crore Ruby Khatun Khatun28 July 2018 10:30 AM ISTHyderabad: Pharma major Dr Reddy's Laboratories reported a nearly eight-fold jump in consolidated profit after tax to Rs 456.1 crore for the first...
Biocon Q1 net profit up 47 percent to Rs 120 crore Ruby Khatun Khatun28 July 2018 10:15 AM ISTNew Delhi: Biotechnology major Biocon reported a 47 percent rise in its consolidated net profit to Rs 120 crore for the quarter ended June 2018 on...
Blue Star Engineering wins order worth Rs 100 crore for supply of 28 Medical CT scanners from UPMHS Ruby Khatun Khatun28 July 2018 9:45 AM ISTMumbai: Air conditioning and commercial refrigeration major, Blue Star said that its wholly owned subsidiary, Blue Star Engineering & Electronics,...
Bristol-Myers to get negative CHMP opinion on renal cancer drugs Ruby Khatun Khatun28 July 2018 9:30 AM ISTNEW YORK: Bristol-Myers Squibb Co said it was told by European regulators that they will recommend against approving the company’s drugs Opdivo and...
Brilinta War: AstraZeneca, Dr Reddys in patent battle over generic version of ticagrelor Ruby Khatun Khatun27 July 2018 3:31 PM ISTNew Delhi: Dr Reddy's Laboratories has been dragged to Delhi High Court by AstraZeneca in order to block the firm from launching the generic versions...
Dr Reddy's launches Hervycta to treat cancer in India Ruby Khatun Khatun27 July 2018 10:30 AM ISTNew Delhi: Drug major Dr Reddy's Laboratories (DRL) announced the launch of Hervycta, indicated for the treatment of certain types of cancer, in...
Zydus gets final approval for Acetylcysteine Injection from USFDA Ruby Khatun Khatun27 July 2018 10:15 AM ISTMumbai: Pharma Major, Zydus Cadila has received the final approval from the USFDA to market Acetylcysteine Injection (US RLD - Acetadote Injection), 6...
Study suggests similarity between biosimilar GBR 310 and omalizumab: Glenmark Ruby Khatun Khatun27 July 2018 10:00 AM ISTNew Delhi: Drug major Glenmark Pharma said that results from a phase 1 study suggest a similarity between the company's proposed biosimilar GBR 310...
New drugs help as AstraZeneca battles through generic losses Ruby Khatun Khatun27 July 2018 9:45 AM ISTLONDON: AstraZeneca's new drugs performed strongly in the second quarter, offering a glimpse of better times ahead as the company struggles with...
